Close Menu
Fund Focus News
    Facebook X (Twitter) Instagram
    Trending
    • What Is TREPS In Mutual Funds? | Business News
    • Mutual funds are taking cash calls—but are they working?
    • Investing in CIBC mutual funds
    • How To Buy Direct Mutual Funds Online In India | Business News
    • Top 3 Tax-saving ELSS Mutual Funds with Highest Returns: Rs 3.5 lakh invested in No. 1 fund has grown to Rs 12.66 lakh in just 5 years
    • Lum Sum vs Income Tax vs Inflation: What will be value of your Rs 1 lakh mutual fund investment in 20 years after paying tax, adjusting to inflation?
    • Invesco MF launches Income Plus Arbitrage Active Fund of Fund
    • SBI Mutual Fund launches AI chatbot ‘SmartAssist’ for WhatsApp-based investing
    Facebook X (Twitter) Instagram
    Fund Focus News
    • Home
    • Bonds
    • ETFs
    • Funds
    • Investments
    • Mutual Funds
    • Property Investments
    • SIP
    Fund Focus News
    Home»Investments»Investing in EMVision Medical Devices (ASX:EMV) five years ago would have delivered you a 419% gain
    Investments

    Investing in EMVision Medical Devices (ASX:EMV) five years ago would have delivered you a 419% gain

    July 14, 2024


    It hasn’t been the best quarter for EMVision Medical Devices Ltd (ASX:EMV) shareholders, since the share price has fallen 13% in that time. But over five years returns have been remarkably great. Indeed, the share price is up a whopping 419% in that time. So we don’t think the recent decline in the share price means its story is a sad one. Only time will tell if there is still too much optimism currently reflected in the share price.

    With that in mind, it’s worth seeing if the company’s underlying fundamentals have been the driver of long term performance, or if there are some discrepancies.

    View our latest analysis for EMVision Medical Devices

    Given that EMVision Medical Devices didn’t make a profit in the last twelve months, we’ll focus on revenue growth to form a quick view of its business development. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. As you can imagine, fast revenue growth, when maintained, often leads to fast profit growth.

    For the last half decade, EMVision Medical Devices can boast revenue growth at a rate of 41% per year. Even measured against other revenue-focussed companies, that’s a good result. Arguably, this is well and truly reflected in the strong share price gain of 39%(per year) over the same period. It’s never too late to start following a top notch stock like EMVision Medical Devices, since some long term winners go on winning for decades. On the face of it, this looks lke a good opportunity, although we note sentiment seems very positive already.

    The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).

    earnings-and-revenue-growthearnings-and-revenue-growth

    earnings-and-revenue-growth

    Balance sheet strength is crucial. It might be well worthwhile taking a look at our free report on how its financial position has changed over time.

    A Different Perspective

    We’re pleased to report that EMVision Medical Devices shareholders have received a total shareholder return of 69% over one year. Since the one-year TSR is better than the five-year TSR (the latter coming in at 39% per year), it would seem that the stock’s performance has improved in recent times. In the best case scenario, this may hint at some real business momentum, implying that now could be a great time to delve deeper. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Even so, be aware that EMVision Medical Devices is showing 2 warning signs in our investment analysis , and 1 of those is potentially serious…

    If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: many of them are unnoticed AND have attractive valuation).

    Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Australian exchanges.

    Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

    Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com



    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email

    Related Posts

    Columbia Threadneedle Investments appoints new sales head for the Middle East and Africa

    July 2, 2025

    Saudi Red Sea Authority regulates coastal tourism and attracts investments

    July 2, 2025

    HBM Healthcare Investments lance un programme de rachat de 10 % de son capital social

    July 1, 2025
    Leave A Reply Cancel Reply

    Top Posts

    What Is TREPS In Mutual Funds? | Business News

    July 3, 2025

    Qu’est-ce qu’un green bond ?

    December 7, 2017

    les cat’ bonds deviennent incontournables

    September 5, 2018

    Quel est le rôle du service des impôts des particuliers (SIP) ?

    May 7, 2020
    Don't Miss
    Mutual Funds

    What Is TREPS In Mutual Funds? | Business News

    July 3, 2025

    Last Updated:July 03, 2025, 08:28 ISTTREPS or Treasury Bills Repurchase is an effective and secure…

    Mutual funds are taking cash calls—but are they working?

    July 2, 2025

    Investing in CIBC mutual funds

    July 2, 2025

    How To Buy Direct Mutual Funds Online In India | Business News

    July 2, 2025
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    EDITOR'S PICK

    5 Best Cryptocurrency ETFs – Securities.io

    July 14, 2024

    3 Wealth-Building Vanguard ETFs to Buy Hand Over Fist

    October 27, 2024

    Federal Funds and State Regulations: Pennsylvania’s Broadband Expansion in Jeopardy

    August 17, 2024
    Our Picks

    What Is TREPS In Mutual Funds? | Business News

    July 3, 2025

    Mutual funds are taking cash calls—but are they working?

    July 2, 2025

    Investing in CIBC mutual funds

    July 2, 2025
    Most Popular

    ₹10,000 monthly SIP in this debt mutual fund has grown to over ₹70 lakh in 23 years

    June 13, 2025

    ₹1 lakh investment in these 2 ELSS mutual funds at launch would have grown to over ₹5 lakh. Check details

    April 25, 2025

    ZIG, BUZZ, NANC, and KRUZ

    October 11, 2024
    © 2025 Fund Focus News
    • Get In Touch
    • Privacy Policy
    • Terms and Conditions

    Type above and press Enter to search. Press Esc to cancel.